Executive Leadership
Tim Yale
Chairman, Co-Founder
Eric Katz
President, Co-Founder
Phil Oakley
Vice President Public Sector
Drug Discovery & Development
Max Arella, Ph.D.
Co-Founder
Science Committee
Tokuhiro Chano, M.D., Ph.D.
Department of Clinical Laboratory Medicine and Medical Genetics
Shiga University
Nahum Sonenberg, Ph.D.
Chair of Biochemistry
McGill University
Michael Gertner, M.D.
Robert Redfield, M.D.
Strategic Advisor
Former CDC Director
Drug Approval
Michael A. Zemel, Ph.D.
Chief Scientific Officer Kinexum Services
Davey Smith, M.D.
UCSD - Head of Virology
Chief of Infectious Diseases and Global Public Health
HHS Co-ChaIr Activ – 2 COVID-19
Government Affairs & National Security Strategy
Douglas Andrew Smith
Former Asst. Secretary US DHS Government affairs, national security strategy.
Hon. Alphonso Maldon, Jr.
Former Assist. Secretary of Defense
F. Whitten Peters
Former U.S. Secretary of the Air Force
Strategic Partners
Linden Blue
Co-Owner of General Atomics
Henry “Hank” Nordhoff
Chairman and CEO of Banyan Biomarkers, Inc.
